Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 25.27

+0.7%

9:41 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Anthony Wong who wrote (418)	6/26/1998 2:41:00 PM
From: Anthony Wong	Read Replies (1) of 1722

Bristol-Myers Squibb Co. (BMY) rose as much as 3 1/2 to 117 1/2 as analyst David Lippman of Prudential Securities Inc. raised his 12-month price target on the pharmaceutical company to 135 from 123 and reiterated his ''buy'' rating. Lippman said that prescription sales for the company's two cardiovascular drugs, Avapro and Plavis, are moving steadily higher, and he thinks they will add more to future earnings. Also, it appears that three of the drugmaker's potentially important new drugs are making good progress in clinical trials, and that the company may increase its dividend later this year, he said. Source: Bloomberg newswire, June 26, 1998 11:32 a.m. PT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next